RxDoctor Payments Data

Katherine Thompson, NP

Family · Duluth, GANPI 1780128983

Payments from drug & device makers

$1,063in general payments, 2019–2025

Across 54 payments — averaging $19.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$333
  • Merck$263
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$136
  • Pfizer$110
  • Cvrx, Inc.$36
  • E.r. Squibb & Sons, L.L.C.$28
  • plus $157 from 7 others

What the payments were for

  • Food & beverage$1,063100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,063 in reported general payments places this provider in the 65th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Medicare billing

Part B allowed, 2024
$24,023
Medicare patients
186
Services billed
373

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VyndamaxTafamidis14$582,998
EntrestoSacubitril/Valsartan274$276,238
JardianceEmpagliflozin248$223,034
EliquisApixaban85$88,794
FarxigaDapagliflozin Propanediol43$33,699
TradjentaLinagliptin25$16,990
XareltoRivaroxaban19$10,517
Torsemide217$4,031
Bumetanide72$3,391
Metoprolol Succinate204$2,652
Spironolactone312$2,296
Metolazone43$1,605
Potassium Chloride58$1,467
Hydralazine Hcl81$1,261
Atorvastatin Calcium123$1,231

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerVyndamax, Eliquis$110$671,79399 claims
NovartisEntresto$20$276,238274 claims
Boehringer IngelheimJardiance, Tradjenta$333$240,024273 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 6,258 family providers in Georgia.

Other family in Duluth

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →